News
How AI-Powered Imaging Systems Are Solving Healthcare’s Radiologist Shortage Crisis
Healthcare systems face growing imaging volumes and a limited number of radiology specialists to handle them. AI-powered imaging systems can help close this gap by streamlining routine tasks and giving radiologists more time for complex cases and clinical decisions....
Business & Industry
Eli Lilly’s $3.5 Billion Manufacturing Campus Advances in Upper Macungie, Pennsylvania
A planned $3.5 billion pharmaceutical manufacturing campus in Upper Macungie Township, Pennsylvania, has advanced through the local development process after the Upper Macungie Planning Commission recommended final subdivision and land development approval on August 19, 2026. Known as Project...
News
Overcoming Resistance-Associated Substitutions (RASs) to Direct-Acting Antivirals
Alt tag: Scientific illustration of Hepatitis C virus interacting with a human liver cell, showing host-targeting molecules disrupting viral entry, replication, and lipid-dependent assembly to overcome antiviral resistance.
While the introduction of Direct-Acting Antivirals has helped cure Hepatitis C, making...
News
Genentech Completes Structural Framework at New NC Manufacturing Facility
Genentech raised the final beam of its new Holly Springs, North Carolina manufacturing facility on August 18, marking the completion of the structural framework for what will become the company's first East Coast manufacturing site in the United States.
The...
Business & Industry
Chugai Pharmaceutical and GSK Sign Exclusive License Agreement for Anti-Dengue Antibody AID351
Japan-based Chugai Pharmaceutical has entered into an exclusive license agreement with British pharmaceutical company GlaxoSmithKline (GSK) for the anti-dengue virus antibody known as AID351, in a move that advances global efforts to combat one of the world's most widespread...
BioPharma
Lonza Launches Rapid Media Prototyping Service to Accelerate Biopharmaceutical Development
Lonza has announced the launch of its Rapid Media Prototyping Service (RaMP) — a solution designed to give biopharmaceutical companies faster access to custom liquid and powder media for screening, process confirmation, and early development.
Delivering Speed and Flexibility in...
BioPharma
Sandoz Expands Global Pipeline with Multi-Product Biosimilar Agreement
Sandoz has entered into a collaboration agreement with Shanghai Henlius Biotech to co-develop a series of new biosimilars across international markets. The milestone-based transaction carries a total consideration of up to $322m, including near-term payments of up to $100.5m...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.